Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


1.		Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				EFC6125 EudraCT : 2005-005026-31, AVE0005A /3001, NCT00327444


2.		Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-Small-Cell-Lung Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				ARD6123 AVE0005B/2001, NCT00284141


3.		Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Completed				18 and over				Pharmaceutical / Industry				ARD6122 AVE0005, NCT00327171

Last Modified: 3/14/2008 First Published: 8/18/2006


4.		Phase II Study of VEGF Trap in Patients With Previously Treated Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				NCCTG-N0537 N0537, NCT00369655

Last Modified: 1/9/2009 First Published: 11/22/2006


5.		Phase II Study of VEGF Trap in Patients With Previously Treated Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				NCI				PMH-PHL-050 PHL-050, NCI-7498, NCT00407654

Last Modified: 9/17/2008 First Published: 11/22/2006


6.		Phase II Study of VEGF Trap in Patients With Recurrent, Locoregionally Advanced, or Metastatic Transitional Cell Carcinoma of the Urothelium

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Closed				18 and over				NCI				CCC-PHII-76 7533, NCT00407485


7.		AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Completed				18 and over				Pharmaceutical / Industry				ARD6772 EUDRACT: 2006-000604-16, NCT00396591

Last Modified: 6/3/2008 First Published: 4/13/2007


8.		Phase II Study of VEGF Trap in Patients With Recurrent or Persistent Endometrial Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Temporarily closed				18 and over				NCI				GOG-0229F GOG-0229F, NCT00462826

Last Modified: 4/21/2005 First Published: 5/1/2002


9.		Phase I Study of VEGF Trap in Patients With Incurable Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				25 and over				NCI, Pharmaceutical / Industry				MSKCC-01131 REGENERON-VGFT-ST-0103, NCI-G02-2065, NCT00036946

Last Modified: 4/7/2005 First Published: 9/1/2002


10.		Phase I Extension Study of VEGF Trap in Patients With Incurable Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				25 and over				NCI, Pharmaceutical / Industry				MSKCC-02020 REGENERON-VGF-ST-0105, NCI-G-02-2101, NCT00045266

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute